PhoenixBio Co (TSE:6190) Inventories, Work In Process: 円42 Mil (As of Mar. 2026)


TSE:6190 PhoenixBio Co Ltd TSE:6190
57 GF Score
Price 円325.00
GF Value 円360.39
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is PhoenixBio Co Inventories, Work In Process?

PhoenixBio Co TSE:6190 -1.52% 57 Inventories, Work In Process is 円42 Mil as of Mar. 2026. GuruFocus rates TSE:6190 with a GF Score™ of 57/100 and a GF Value™ of 円360.39 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. PhoenixBio Co's work in process for the quarter that ended in Mar. 2026 was 円42 Mil.


PhoenixBio Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for PhoenixBio Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhoenixBio Co Inventories, Work In Process Chart

PhoenixBio Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.32 115.04 124.30 44.90 42.01

PhoenixBio Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.30 134.31 44.90 42.33 42.01
TSE:6190
57GF Score
PhoenixBio Co Ltd TSE:6190
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhoenixBio Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of 円42 Mil mean?
PhoenixBio Co (TSE:6190) has a Inventories, Work In Process of 円42 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on PhoenixBio Co and its competitors.
Is PhoenixBio Co's Inventories, Work In Process too high?
PhoenixBio Co's current Inventories, Work In Process is 円42 Mil. Overall, PhoenixBio Co has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Inventories, Work In Process compare to VRTX and REGN?
PhoenixBio Co's Inventories, Work In Process of 円42 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on PhoenixBio Co and its competitors. PhoenixBio Co's current Inventories, Work In Process is 円42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Modestly Undervalued. The stock's GF Value™ is 円360.39, compared to a current price of 円325.00 — trading 9.8% below its estimated fair value. The current Inventories, Work In Process is 円42 Mil. PhoenixBio Co's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Inventories, Work In Process is 円42 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhoenixBio Co (TSE:6190) Overvalued in 2026?

Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued. The current stock price of 円325.00 is trading 9.8% below its estimated GF Value™ of 円360.39. GuruFocus considers PhoenixBio Co to be Modestly Undervalued.

Key valuation signals for TSE:6190:

  • Inventories, Work In Process: 円42 Mil
  • GF Value™: 円360.39 vs. price of 円325.00 (9.8% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhoenixBio Co Business Description

Address 3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
57GF Score

Get the complete analysis for TSE:6190

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円325.00
Price
円360.39
GF Value